Palliative care in intensive care.

Authors:
Neukirchen M; Metaxa V; Schaefer MS.

Journal:
Intensive Care Med

Publication Year: 2023

DOI:
10.1007/s00134-023-07260-z

PMCID:
PMC10709230

PMID:
38010381

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Intensive Care Med

Abbreviation: Intensive Care Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial.
Meersch M; Weiss R; Strauß C and 11 more (2024) - Transparency Score: 4/6
Clinical practice and effect of carbon dioxide on outcomes in mechanically ventilated acute brain-i…
Robba C; Battaglini D; Abbas A and 10 more (2024) - Transparency Score: 4/6
Equity in patient care in the intensive care unit.
Kotfis K; Olusanya S; Modra L. (2024) - Transparency Score: 2/6
Long-term outcomes with haloperidol versus placebo in acutely admitted adult ICU patients with deli…
Mortensen CB; Andersen-Ranberg NC; Poulsen LM and 23 more (2024) - Transparency Score: 3/6
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute k…
Pickkers P; Angus DC; Bass K and 27 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflicts of interestMN has no conflicts of interest. VM has no conflicts of interest. MSS has received a grant for investigator-initiated studies from Merck & Co unrelated to this manuscript. He has received lecture fees from Mindray Medical and is supported by an unrestricted philanthropic grant from Jeff and Judy Buzen. Conflicts of interest MN has no conflicts of interest. VM has no conflicts of interest. MSS has received a grant for investigator-initiated studies from Merck & Co unrelated to this manuscript. He has received lecture fees from Mindray Medical and is supported by an unrestricted philanthropic grant from Jeff and Judy Buzen."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025